학술논문

Pharmacodynamic relationship between PCSK9, alirocumab, and LDL-C lowering in the ODYSSEY CHOICE I trial
Document Type
Article
Source
In Journal of Clinical Lipidology September-October 2020 14(5):707-719
Subject
Language
ISSN
1933-2874